Publications found:
36,694
Sort by:
Dendritic Cell Cancer Vaccines Market - 2024-2031
US$ 3,400.00
The Dendritic Cell Cancer Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to d...
January 2024
56 pages
Refractory Status Drugs Epileptics Market - 2024-2031
US$ 3,400.00
The Refractory Status Drugs Epileptics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
January 2024
60 pages
Urinary Tract Infection Therapeutics Market - 2024-2031
US$ 3,400.00
The Urinary Tract Infection Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresigh...
January 2024
62 pages
Drugs for Vulvovaginal Candidiasis Market - 2024-2031
US$ 3,400.00
Drugs for Vulvovaginal Candidiasis Marketis is growing with a CAGR of 3.20% during the forecast period 2026-2035. The Drugs for Vulvovaginal Candidiasis Market emerges as a key focus in DataM Intellig...
January 2024
60 pages
Varicella Attenuated Live Vaccine Market - 2024-2031
US$ 3,400.00
Varicella Attenuated Live Vaccine Marketis is growing with a CAGR of 5.00% during the forecast period 2026-2035. The Varicella Attenuated Live Vaccine Market emerges as a key focus in DataM Intelligen...
January 2024
59 pages
Myocardial Infarction Drugs Market - 2024-2031
US$ 3,400.00
The Myocardial Infarction Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deli...
January 2024
53 pages
Antacids Market - 2024-2031
US$ 3,400.00
Antacids Marketis is growing with a CAGR of 3.10% during the forecast period 2026-2035. The Antacids Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned resear...
January 2024
34 pages
Microscopic Polyangiitis (MPA) Treatment Market - 2024-2031
US$ 3,400.00
Microscopic Polyangiitis (MPA) Treatment Marketis is growing with a CAGR of 5.50% during the forecast period 2026-2035. The Microscopic Polyangiitis (MPA) Treatment Market emerges as a key focus in Da...
January 2024
66 pages
Polycystic Kidney Disease Market - 2024-2031
US$ 3,400.00
Polycystic Kidney Disease Market reached US$ 769 million in 2031 and, growing with a CAGR of 5.80% during the forecast period 2031-2035. The Polycystic Kidney Disease Market emerges as a key focus in...
January 2024
51 pages
South America Constipation Market - 2024-2031
US$ 2,499.00
South America Constipation Market reached in and is expected to reach by , growing with a CAGR of 0.00% during the forecast period 2026-. The South America Constipation Market emerges as a key focus...
January 2024
53 pages
Spinal Muscular Atrophy (SMA) Treatment Market - 2024-2031
US$ 3,400.00
The Spinal Muscular Atrophy (SMA) Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fores...
January 2024
65 pages
Candidiasis Therapeutics Market - 2024-2031
US$ 3,400.00
Candidiasis Therapeutics Marketis is growing with a CAGR of 5.30% during the forecast period 2026-2035. The Candidiasis Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth...
January 2024
50 pages
Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method (Chemical Synthesis and Non-Chemical Synthesis), Type of Chemical Synthesis (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis and Hybrid Phase Peptide Synthesis), Contract Manufacturing Organization Size (Small, Mid-sized, and Large Companies), Key Geographical Regions (North America, Europe, and Asia-Pacific and Rest of the World)
US$ 4,799.00
Peptide Synthesis Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Peptide Synthesis Method (Chemical Synthesis and Non-Chemical Synthesis), Type of Chemical Synthesis...
January 2024
390 pages
Scleroderma Therapeutics Market - 2024-2031
US$ 3,400.00
Scleroderma Therapeutics Marketis is growing with a CAGR of 5.98% during the forecast period 2026-2035. The Scleroderma Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth...
January 2024
50 pages
Spain Opioid Induced Constipation Market - 2024-2031
US$ 1,899.00
Spain Opioid Induced Constipation Market reached in and is expected to reach by , growing with a CAGR of 4.40% during the forecast period 2026-. The Spain Opioid Induced Constipation Market emerges as...
January 2024
59 pages
Von Willebrand Disease Treatment Market - 2024-2031
US$ 3,400.00
Von Willebrand Disease Treatment Market reached US$ 728.1 million in 2031 and, growing with a CAGR of 6.50% during the forecast period 2031-2035. The Von Willebrand Disease Treatment Market emerges as...
January 2024
58 pages
Acute Lung Injury Market - 2024-2031
US$ 3,400.00
Acute Lung Injury Marketis is growing with a CAGR of 5.80% during the forecast period 2026-2035. The Acute Lung Injury Market emerges as a key focus in DataM Intelligence latest in-depth analysis, whe...
January 2024
43 pages
Prefilled Syringes Market (7th Edition), Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic Prefilled Syringes), Therapeutic Area (Therapeutic Syringes - Blood Disorders, Infectious Diseases, Autoimmune Disorders, Oncological Disorders, Cardiovascular Disorders, Respiratory Disorders, Neurological Disorders, Metabolic Disorders, Ophthalmic Disorders, Orthopedic Disorders and Others), Type of Molecule (Therapeutic Syringes - Proteins, Antibodies, Peptides, Small Molecules, Vaccines and Cell Therapies), Type of Barrel Material (Glass Syringes and Plastic Syringes), Number of Barrel Chamber (Single Chamber Syringes and Dual Chamber Syringes), Type of Needle System (Staked Needle Syringes and Luer Syringes), Usability of Syringe (Disposable Syringes and Reusable Syringes), Type of Syringe (Conventional Syringes and Safety Syringes), Type of Packaging (Bulk Syringes and Nested Syringes) and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America)
US$ 4,799.00
Prefilled Syringes Market (7th Edition), Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe (Specialty Prefilled Syringes, Therapeutic Prefilled Syringes and Cosmetic...
January 2024
867 pages
Global Markets for Generic Drugs
US$ 4,650.00
The global market for generic drugs should reach $533 billion by 2021 ... from 2016 to 2021. The BRIC markets region of the generic drugs industry is the largest market. The market is expected to grow from $132 ... 2016-2021. The North America region of the generic drugs industry is expected to grow from $112 billion ...
January 2024
126 pages
Exocrine Pancreatic Insufficiency Market - 2024-2031
US$ 3,400.00
Exocrine Pancreatic Insufficiency Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Exocrine Pancreatic Insufficiency Market emerges as a key focus in DataM Intelligen...
January 2024
59 pages
Meningitis Vaccines Market - 2024-2031
US$ 3,400.00
Meningitis Vaccines Marketis is growing with a CAGR of 9.60% during the forecast period 2026-2035. The Meningitis Vaccines Market emerges as a key focus in DataM Intelligence latest in-depth analysis,...
January 2024
45 pages
Therapeutic Vaccine Market - 2024-2031
US$ 3,400.00
The Therapeutic Vaccine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpa...
January 2024
45 pages
Fondaparinux Market - 2024-2031
US$ 3,400.00
The Fondaparinux Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallele...
January 2024
38 pages
Acromegaly Treatment Market - 2024-2031
US$ 3,400.00
Acromegaly Treatment Market reached US$ 2.1 billion in 2031 and, growing with a CAGR of 7.40% during the forecast period 2031-2035. The Acromegaly Treatment Market emerges as a key focus in DataM Inte...
January 2024
46 pages
Fatty Acid Oxidation Disorder Drugs Market - 2024-2031
US$ 3,400.00
The Fatty Acid Oxidation Disorder Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
January 2024
61 pages
Pompe Disease Therapeutics Market - 2024-2031
US$ 3,400.00
Pompe Disease Therapeutics Market reached USD 1.9 billion in 2031 and, growing with a CAGR of 4.30% during the forecast period 2031-2035. The Pompe Disease Therapeutics Market emerges as a key focus i...
January 2024
52 pages
Chemotherapy Induced Anemia Market - 2024-2031
US$ 3,400.00
Chemotherapy Induced Anemia Market reached USD 3,893.5 million in 2031 and, growing with a CAGR of 7.20% during the forecast period 2031-2035. The Chemotherapy Induced Anemia Market emerges as a key f...
January 2024
53 pages
Myopia Treatment Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (High Myopia, Degenerative Myopia, Progressive Myopia), Treatment [Low-Dose Atropine Eye Drops, Contact Lenses, Ortho-K, and Refractive Surgery (LASIK, PRK)], Age Group (Adult Myopia and Childhood Myopia), End User (Hospitals and Clinics, Specialty Clinics, and Refractive Surgery Centers), and Geography
US$ 5,190.00
The global myopia treatment market is expected to reach US$ 19.571 billion in 2030 from US$ 10.276 billion in 2022. The market is estimated to grow with a CAGR of 8.39% from 2022 to 2030. Key factors...
January 2024
206 pages
Tumor Necrosis Factor Inhibitor Drugs Market - 2024-2031
US$ 3,400.00
Tumor Necrosis Factor Inhibitor Drugs Marketis is growing with a CAGR of 16.30% during the forecast period 2026-2035. The Tumor Necrosis Factor Inhibitor Drugs Market emerges as a key focus in DataM I...
January 2024
63 pages
Motion Sickness Treatment Market - 2024-2031
US$ 3,400.00
Motion Sickness Treatment Marketis is growing with a CAGR of 3.00% during the forecast period 2026-2035. The Motion Sickness Treatment Market emerges as a key focus in DataM Intelligence latest in-dep...
January 2024
51 pages
Non-Opioid Pain Treatment Market - 2024-2031
US$ 3,400.00
Non-Opioid Pain Treatment Marketis is growing with a CAGR of 8.00% during the forecast period 2026-2035. The Non-Opioid Pain Treatment Market emerges as a key focus in DataM Intelligence latest in-dep...
January 2024
51 pages
Overactive Bladder Treatment Market - 2024-2031
US$ 3,400.00
Overactive Bladder Treatment Marketis is growing with a CAGR of 3.60% during the forecast period 2026-2035. The Overactive Bladder Treatment Market emerges as a key focus in DataM Intelligence latest...
January 2024
54 pages
Vaccine Adjuvant Market Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Adjuvant Class (Mineral Salt Adjuvant, Emulsion Adjuvant, Liposome Adjuvant, and Others), Type (Human Vaccine Adjuvant and Veterinary Vaccine Adjuvant), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
US$ 5,190.00
The vaccine adjuvants market is expected to grow from US$ 2.482 billion in 2022 to US$ 6.931 billion by 2028; it is expected to grow at a CAGR of 13.7% from 2022 to 2028. Support for developments in a...
January 2024
155 pages
IgG4-Related Disease Market - 2024-2031
US$ 3,400.00
The IgG4-Related Disease Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
January 2024
46 pages
Osteoarthritis Drugs Market - 2024-2031
US$ 3,400.00
Osteoarthritis Drugs Marketis is growing with a CAGR of 8.80% during the forecast period 2026-2035. The Osteoarthritis Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analys...
January 2024
47 pages
Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted (Bladder Cancer, Blood / Hematologic Cancer, Breast Cancer, Cervical Cancer, Gastrointestinal Cancer, Head and Neck Squamous Cell Cancer, Lung Cancer, Skin Cancer and Others), Route of Administration (Oral, Intravenous and Others), Type of Molecule (Small Molecules and Biologics), Drug Class (Kinase Inhibitors, Enzyme Inhibitors, Immune Checkpoint Inhibitors and Others), Key Geographical Regions (North America (US, Canada), Europe (France, Germany, Italy, Spain and UK), Asia (China, Japan, Korea and India), Middle East and North Africa (UAE, Israel, Qatar, Rest of Middle East and North Africa) and Latin America (Brazil, Argentina, Chile and Rest of Latin America), Leading Drug Developers and Sales Forecast
US$ 4,799.00
Oncology Precision Medicine Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Cancer Targeted (Bladder Cancer, Blood / Hematologic Cancer, Breast Cancer, Cervical Cancer...
January 2024
468 pages
Global Markets for Orphan Drugs
US$ 4,650.00
Report : The scope of this study includes orphan drugs used in the global pharmaceutical markets. This report analyzes the therapeutic applications of orphan drugs in rare and orphan diseases as well...
January 2024
189 pages
Isocitrate Dehydrogenase Inhibitors Market - 2024-2031
US$ 3,400.00
The Isocitrate Dehydrogenase Inhibitors Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
January 2024
61 pages
Human Vaccine Adjuvants Market Size and Forecast (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Particulate Adjuvant, Emulsion Adjuvant, Combination Adjuvant, and Others), Application (Influenza, Hepatitis, Human papilloma virus (HPV), and Others), End User (Pharmaceutical and Biotechnology Companies, CMOs and CROs, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
US$ 5,190.00
The global human vaccine adjuvants market is expected to reach US$ 4.489 billion in 2030 from US$ 1.571 billion in 2022. The market is estimated to grow with a CAGR of 14.0% from 2022 to 2030. Key fac...
January 2024
199 pages
Medical Aesthetics Market - Distribution by Type of Product and / or Device Offered (Botox, Dermal Fillers, Chemical Peels, Body Contouring, Gluteal Implants, Hair Removal, Breast Implants and Other Products and / or Devices), Type of Procedure (Non Invasive, Minimally Invasive and Invasive), End User (Hospitals, Clinics / Med Spas and Dermatology / Cosmetology Centers, and Other end users), Gender (Male and Female), Distribution Channel (Direct Distribution and Indirect Distribution), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America): Industry Trends and Global Forecasts
US$ 4,799.00
The medical aesthetics market is expected to reach USD 32 billion by 2023 anticipated to grow at a CAGR of 9.6% during the forecast period 2023-2035. The demand for medical aesthetic solutions has sur...
January 2024
-
Herbal Medicine Market Size, Share, and Analysis, By Form (Powder, Liquid & Gel, Tablets & Capsules), By Application (Pharmaceutical & Nutraceutical, Food & Beverages, Personal Care & Beauty Products), By Distribution Channel (Hospital & Retail Pharmacies, E-Commerce) and Regional Forecasts, 2022-2032
US$ 4,950.00
Herbal Medicine Market Size, Share, and Analysis, By Form (Powder, Liquid & Gel, Tablets & Capsules), By Application (Pharmaceutical & Nutraceutical, Food & Beverages, Personal Care & Beauty Products)...
January 2024
543 pages
Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimmune/Inflammation, Cardiovascular Disease, Metabolic/Endocrinology, Infectious Disease, Oncology, Genitourinary, Ophthalmology, Others) and Regional Forecasts, 2022-2032
US$ 4,950.00
Virtual Clinical Trials Market Size, Share, and Analysis, By Study Type (Interventional, Observational, Expanded Access), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication (CNS, Autoimm...
January 2024
430 pages
Diabetic Food Market Size, Share, and Analysis By Product Type (Confectionery, Bakery Product, Dairy Product, Dietary Beverages, and Others), By Distribution Channel (Super Market, Hyper Market, and Grocery Stores, and Others), and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2023-2032
US$ 5,150.00
Diabetic Food Market Size, Share, and Analysis By Product Type (Confectionery, Bakery Product, Dairy Product, Dietary Beverages, and Others), By Distribution Channel (Super Market, Hyper Market, and G...
January 2024
461 pages
Global Pharmaceutical Manufacturing Industry 2022-2032 by Formulation, Route of Administration, Consumer Group, Therapeutic Application, Drug Type, Distribution Channel, Manufacturing Facility, and Region: Trend Forecast and Growth Opportunity
US$ 2,720.00
Global pharmaceutical manufacturing industry market will reach $25.77 billion by 2032, growing by 9.3% annually over 2022-2032. The growth is driven by the increased drug approvals, increasing prevale...
December 2023
228 pages
